We are live on
!
Find out more
Corvus Pharmaceuticals
CRVS
CRVS
38 hedge funds and large institutions have $67.5M invested in Corvus Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 12 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
1,469% more call options, than puts
Call options by funds: $204K | Put options by funds: $13K
21% more capital invested
Capital invested by funds: $55.6M → $67.5M (+$11.9M)
0% more funds holding
Funds holding: 38 → 38 (0)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 7
8% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 12
11.73% less ownership
Funds ownership: 73.14% → 61.4% (-12%)
Holders
38
Holders Change
–
Holders Change %
0%
% of All Funds
0.77%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
7
Increased
11
Reduced
12
Closed
7
Calls
$204K
Puts
$13K
Net Calls
+$191K
Net Calls Change
+$191K
Top Buyers
Top Sellers
| 1 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$6.15M |
| 2 |
Millennium Management
New York
|
-$3.24M |
| 3 |
EC
EcoR1 Capital
San Francisco,
California
|
-$2.01M |
| 4 |
Renaissance Technologies
New York
|
-$627K |
| 5 |
BlackRock
New York
|
-$595K |
